PSG significantly reversed the liver injury, decreased the levels of 8-OHDG and phospho-H2AX, and increased the expression of SOD2, which suggested that PSG could alleviate SLI in IBD mice via suppressing oxidative damage to liver tissues. The gene discussed is H2AX; the disease is inflammatory bowel disease.